Skip to content
TrustList
I
Venture capital firm

Immunor

Norwegian vaccine developer using a peptide-based platform for preventive and therapeutic vaccines

Immunor cover

About Immunor

Immunor is a Norwegian vaccine research and development company. It builds vaccines on a patented peptide platform designed to be safe and precise.

What Immunor offers

  • Peptide vaccine platform: the Cell Penetrating Selective Peptide Vaccine Platform, tested clinically for safety and efficacy.
  • Vaccine design: selects antigens for immune stimulation and pairs them with adjuvant strategies.
  • Research partnerships: works with a Tromso centre for quantum molecular sciences to strengthen its analysis.
  • Therapeutic vaccines: aims to help patients needing treatment or prevention where medical need is high.

Who it serves

Patients with unmet medical needs, and partners open to joint work on vaccine development.

Key facts

  • Based in: Norway
  • Origin: formed as a diagnostics company in the mid-1980s
  • Experience: more than 25 years developing peptide-based vaccine technology

Profile written by TrustList from the business's own published information, Oct 2026.

What the business tells TrustList

Founded
2001 (25 years) evidence sent

Ask TrustList to introduce you to Immunor

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Immunor

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Immunor.

Immunor alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Venture capital firm partnering with founders from first idea through to public listing

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups